| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Anti-influenza monoclonal antibody (AIMM Therapeutics) | Phase 1 Clinical | Aimm Therapeutics | Influenza, Human | 詳細 | |
| cH8/1N1 LAIV | Phase 1 Clinical | Icahn School Of Medicine At Mount Sinai | Influenza, Human | 詳細 | |
| Ad4-H5-Vtn (Emergent BioSolutions/National Institute of Allergy and Infectious Diseases) | Phase 1 Clinical | Emergent Biosolutions Inc | Communicable Diseases | 詳細 |